A61K 31/4035
Isoindoles
Official title: Isoindoles, e.g. phthalimide
A61K31/4035 (Isoindoles) appears on 620 US grants and 946 published applications in this corpus.
Search patents in A61K- Granted patents
- 620
- Published applications
- 946
- Assignees
- 411
- Inventors
- 2,037
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 14 | 0 |
| 2000 | 16 | 0 |
| 2001 | 16 | 10 |
| 2002 | 10 | 21 |
| 2003 | 15 | 21 |
| 2004 | 4 | 24 |
| 2005 | 4 | 20 |
| 2006 | 11 | 26 |
| 2007 | 9 | 29 |
| 2008 | 11 | 27 |
| 2009 | 12 | 30 |
| 2010 | 16 | 21 |
| 2011 | 17 | 26 |
| 2012 | 16 | 28 |
| 2013 | 19 | 40 |
| 2014 | 30 | 53 |
| 2015 | 26 | 47 |
| 2016 | 45 | 52 |
| 2017 | 45 | 57 |
| 2018 | 41 | 38 |
| 2019 | 34 | 54 |
| 2020 | 37 | 59 |
| 2021 | 35 | 46 |
| 2022 | 24 | 35 |
| 2023 | 25 | 40 |
| 2024 | 21 | 56 |
| 2025 | 29 | 38 |
| 2026 | 16 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- BCAT modulation11 Aug 2026US 12,703,697 B2Icagen, Inc.
- Compositions for the treatment of hypertension7 Jul 2026US 12,673,047 B2The George Institute for Global Health
- Inhibition of glial cell activation7 Jul 2026US 12,673,957 B2Lapko Inc
- Oral solid chlorthalidone compositions30 Jun 2026US 12,667,554 B1Ingenus Pharmaceuticals, LLC
- Compositions for the treatment of hypertension23 Jun 2026US 12,661,345 B2The George Institute for Global Health
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Compositions for the treatment of hypertension24 Sep 2026US 2026/0284022 A1The George Institute for Global Health
- Combination therapies using immuno-dash inhibitors and pge2 antagonists17 Sep 2026US 2026/0272880 A1Trustees of Tufts College
- Compositions for the treatment of hypertension3 Sep 2026US 2026/0256754 A1The George Institute for Global Health
- Pharmaceutical composition for preventing or treating brain tumor3 Sep 2026US 2026/0256816 A1Astrion Inc.
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Therapeutic inhibitor of vascular smooth muscle cells308US 6,074,659 ANoeRx Corporation · 2000
- Therapeutic inhibitor of vascular smooth muscle cells280US 5,811,447 ANeoRx Corporation · 1998